IL7R and COVID-19: Signaling by CD127/IL-7 is involved in numerous key aspects of T-cell survival and proliferation, therefore, increased CD127 expression levels on T cells could be involved in overcoming lymphopenia in patients with COVID-19 and thus lead to a decrease in lung inflammation.